Skip to main content
13 August 2026
The Jackson Laboratory and GSK Alliance
18 February 2026

The Jackson Laboratory and GSK Alliance Aims to Bridge Discovery-to-Therapy Gap

The Jackson Laboratory–New York Stem Cell Foundation Collaborative announced a five-year strategic research collaboration with GSK focused on advancing human cellular models of neurodegenerative disease, including Alzheimer's disease. The collaboration reflects a strategic focus that brings together human stem cell r…

Scinai
18 February 2026

Scinai Strengthens I&I and CDMO Business via Recipharm Israel Deal

Scinai Immunotherapeutics Ltd., a biopharmaceutical company developing inflammation and immunology (I&I) therapeutics and operating a growing CDMO business, announced that it has acquired 100% of the shares of Recipharm Israel Ltd., which operates Recipharm's site in Yavne, Israel, and entered into a long-term str…

QuidelOrtho and Lifotronic
17 February 2026

QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio

QuidelOrtho has entered a long-term strategic supply agreement with Lifotronic Technology Co., Ltd., to expand QuidelOrtho's global immunoassay portfolio and accelerate customer access to scalable, high quality, cost-efficient solutions across select markets outside the United States. The agreement provides QuidelOrt…

16 February 2026

OpenLab CDS and Analytical Studio Integration Accelerates Pharma R&D Operations

Agilent Technologies, Inc. and Virscidian, LLC announced an expanded collaboration to enhance interoperability between Agilent OpenLab CDS and Virscidian Analytical Studio. The solution enables scientists to seamlessly access chromatography data and orchestrate high-throughput workflows, including purification.  It de…

13 February 2026

BioLife Inks Worldwide Supply Agreement with Qkine

BioLife Solutions, Inc., a leading developer and supplier of bioproduction tools and services for the cell and gene therapy (CGT) market, announces it has entered into a multi-year supply agreement with Qkine Limited under which BioLife will distribute certain cytokine and growth factor products manufactured by Qkine …

11 February 2026

Malaysia Healthcare Expands Cambodia Outreach with MHTC Launch

Malaysia Healthcare Travel Council (MHTC) marked the launch of Malaysia Healthcare Week Phnom Penh 2026 with a hospital introduction session in collaboration with OneHealth Cambodia. This engagement represents MHTC's first official initiative in Cambodia for 2026 and forms part of the Malaysia Year of Medical Tourism …

10 February 2026

Eli Lilly to Acquire Orna Therapeutics in RNA-Based Cell Therapy Deal

Eli Lilly and Company and Orna Therapeutics, Inc., a biotechnology company dedicated to engineering immune cells in vivo, today announced entry into a definitive agreement for Lilly to acquire Orna. Orna is advancing a new class of therapeutics utilizing engineered circular RNA paired with novel lipid nanoparticles t…

Page 15 of 36